Prognostic and predictive factors in endocrine tumours

Histopathology

Volumn 48, Issue 6, 2006, Pages 629-643

  Stephenson, T J ^a,b  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Adrenal; Endocrine; Neuroendocrine; Parathyroid; Prognosis; Thyroid

Indexed keywords

ADRENAL CORTEX TUMOR; CANCER INVASION; CELL HYPERPLASIA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE TUMOR; HISTOPATHOLOGY; HUMAN; PANCREAS TUMOR; PARAGANGLIOMA; PARATHYROID TUMOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; THYROID TUMOR;

DIAGNOSIS, DIFFERENTIAL; ENDOCRINE GLAND NEOPLASMS; GLUCAGON; HUMANS; INSULIN; PEPTIDE HORMONES; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 33645979984     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02380.x     Document Type: Review

References (123)

1. Stephenson TJ Endocrine In Al-Sam S Lakhani SR Davies JD eds A practical atlas of pseudomalignancy Chapter 1 London Edward Arnold 1998 1 19
2. Stephenson TJ Criteria for malignancy in endocrine tumours In Anthony PP MacSween RNM Lowe D eds Recent advances in histopathology Chapter 5 Edinburgh Churchill Livingstone 1997 93 111
3. Solcia E Capella C Kloppel G Tumors of the endocrine pancreas In Rosai J ed Tumors of the pancreasAltas of tumor pathology Washington Armed Forces Institute of Pathology 1995
4. Buchanan KD Johnston CF O'Hare M et al. Neuroendocrine tumors: a European view AmJMed 1986 81 14 22
5. Solcia E Kloppel G Sobin LH et al. Histopathological typing of endocrine tumorsWorld Health Organisation international histological classification of tumors Berlin, Heidelberg Springer-Verlag 2000 61 68
6. Heitz PU Pancreatic endocrine tumors In Kloppel G Heitz PU eds Panreatic pathology Edinburgh Churchill Livingstone 1984 206
7. Yu F Venzon DJ Serrano J et al. Prospective study of the clinical course, prognostic factors, cause of death, and survival in patients with longstanding Zollinger-Ellison syndrome JClinOncol 1999 17 615 630
8. Rindi G Capella C Solcia E Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors JMolMed 1998 76 413 420
9. Heitz PU Momminoth P Perren A et al. Pancreatic endocrine tumours: Introduction In DeLellis RA Lloyd RV Heitz PU Eng C eds World Health Organisation international classification of tumoursPathology and genetics of tumours of endocrine organs Lyon IARC Press 2004 177 182
10. Heymann MF Joubert M Nemeth J et al. Prognostic and immunohistochemical validation of the Capella classification of pancreatic neuroendocrine tumours: an analysis of 82 sporadic cases Histopathology 2000 36 421 432
11. Deshpande V Fernandez-delCastillo C Muzikansky A et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumours AmJSurgPathol 2004 28 1145 1153
12. Bordi C D'Adda T Pizzi S Crafa P Rindi G The assessment of malignancy in endocrine tumours of the gastrointestinal tract CurrDiagnPathol 2002 8 421 429
13. Dixon MF Minimum dataset for the histopathological reporting of gastric carcinoma London Royal College of Pathologists 2000
14. Quirke P Williams GT Minimum dataset for the histopathological reporting of colorectal carcinoma London Royal College of Pathologists 1998
15. Campbell F Bennett MK Foulis AK Minimum dataset for the histopathological reporting of pancreatic, ampulla of vater and bile duct carcinoma London Royal College of Pathologists 2002
16. Ramage JK Davies AHG Ardill J et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours Gut 2005 54 Suppl. IV
17. Stamm B Hacki WH Kloppel G et al. Gastrin producing tumors and the Zollinger-Ellison syndrome In Dayal Y ed Endocrine pathology of the gut and pancreas Boca Raton CRC Press 1991 155
18. Solcia E Rindi G Paolotti D La Rosa S Capella C Fiocca R Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract AnnOncol 1999 10 Suppl. 2 S9 15
19. Bordi C Endocrine tumors of the pancreas: the pathologist's approach ActaBio-Medica de 1'Ateneo Parmense 1993 64 195 204
20. Graeme-Cook F Nardi G Compton CC Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas AmJClinPathol 1990 93 273 276
21. Graeme-Cook F Bell DA Flotte TJ et al. Aneuploidy in pancreatic insulinomas does not predict malignancy Cancer 1990 66 2365 2368
22. Gentil Perrett A Mosnier JF Buono JP et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors AmJClinPathol 1998 109 286 293
23. Chan JKC Tsang YW Endocrine malignancies that may mimic benign lesions SeminDiagnPathol 1995 12 45 63
24. Sandelin K Parathyroid carcinoma Cancer TreatRes 1997 89 183 192
25. LiVolsi VA Asa SL Endocrine pathology Edinburgh Churchill Livingstone 2002
26. DeLellis RA Tumors of the parathyroid gland Atlas of tumor pathology Third series, Fasicle 6 Washington Armed Forces Institute of Pathology 1993 93 94
27. Shane E Parathyroid carcinoma JClinEndocrinolMetab 2001 86 485 493
28. LiVolsi VA Hamilton R Intraoperative assessment of paprathyroid gland pathology. A common view from the surgeon and the pathologist AmJClinPathol 1994 102 365 373
29. Wang CA Gaz RD Natural history of parathyroid carcinoma. Diagnosis, treatment, and results AmJSurg 1985 149 522 527
30. Obara T Fujimoto Y Diagnosis and treatment of patients with parathyroid carcinoma: an update and review World JSurg 1991 15 738 744
31. Schantz A Castleman B Parathyroid carcinoma. A study of 70 cases Cancer 1973 31 600 605
32. Smith JH Coombs RRH Histological diagnosis of carcinoma of the parathyroid gland JClinPathol 1984 37 1370 1378
33. Johnson SJ Sheffield EA McNicol A-M Examination of parathyroid gland specimens JClinPathol 2005 58 338 342
34. Obara T Okamoto T Kanbe M Iihara M Functioning parathyroid carcinoma: clinicopathologic features and rational treatment SeminSurgOncol 1997 13 134 141
35. Aldinger KA Hickey RC Ibanez ML Samaan NA Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer Cancer 1982 49 388 397
36. Abbona GC Papotti M Gasparri G Bussolati G Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining HumPathol 1995 26 135 138
37. Kameyama K Takami H Umemura S et al. PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas AmJSurgOncol 2000 7 301 304
38. DeLellis RA Does the evaluation of proliferative activity predict malignancy or prognosis in endocrine tumors? HumPathol 1995 26 131 134
39. Snover DC Foucar K Mitotic activity in benign parathyroid disease AmJClinPathol 1981 75 345 347
40. Hakim JP Levine MA Absence of p53 point mutations in parathyroid adenoma and carcinoma JClinEndocrinMetab 1994 78 103 106
41. Cohn K Parathyroid carcinoma: the Lahey clinic experience Surgery 1985 98 1095 1100
42. Chu KC Kramer BS Cancer patterns in the United States In Greenwald P Kramer BS Weed DL eds Cancer prevention and control New York Marcel Dekker 1995 37
43. Sipponen P Louhimo J Nordling S et al. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients Tumor Biol 2005 26 57 61
44. Hadar T Mor C Shvero J Levy R Segal K Anaplastic carcinoma of the thyroid EurJSurgOncol 1993 19 511 516
45. International Union Against Cancer. TNM atlas: illustrated guide to the TNM classification of malignant tumours 5th edn Heidelberg Springer Verlag 2005
46. Royal College of Physicians of London. Guidelines for the management of thyroid cancer in adults London British Thyroid Association and The Royal College of Physicians of London 2002
47. Hapke MR Dehner LP The optically clear nucleus. A reliable sign of papillary carcinoma of the thyroid AmJSurgPathol 1979 3 31 38
48. Anderson CE McLaren KM Best practice in thyroid pathology JClinPathol 2003 56 401 405
49. Baloch ZW LiVolsi VA Follicular patterned lesions of the thyroid: the bane of the pathologist AmJClinPathol 2002 117 143 150
50. LiVolsi VA Fadda G Baloch ZW Prognostic factors in well-differentiated thyroid cancer Rays 2000 25 163 175
51. Hedinger C Williams ED Sobin LH Histological typing of thyroid tumoursWHO international histological classification of tumours 4th edn Berlin Springer-Verlag 1988
52. Strate SM Lee EL Childers JH Occult papillary carcinoma of the thyroid with distant metastases Cancer 1984 54 1093 1100
53. Stephenson TJ Commentary: Papillary carcinoma of the thyroid - difficult yet fascinating model of oncogenesis and tumour progression Histopathology 2004 44 498 500
54. Hubert JP Kiernan PD Beahrs OH et al. Occult papillary carcinoma of the thyroid ArchSurg 1980 115 394 398
55. Baudin E Travagli JP Ropers J et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute Experience Cancer 1998 83 553 559
56. Rossi RL Majlis S Rossi RM Thyroid cancer SurgClinNorthAm 2000 80 571 580
57. DeGroot LJ Kaplan EL Straus FH Shukla MS Does the method of management of papillary thyroid carcinoma make a difference in outcome? World JSurg 1994 18 123 130
58. Rosai J Zampi G Carcangiu ML Papillary carcinoma of the thyroid AmJSurgPathol 1983 7 809 862
59. Bell CD Coire C Treger T et al. The 'dark nucleus' and disruptions of the follicular architecture: possible new histological aids for the diagnosis of the follicular variant of papillary carcinoma of the thyroid Histopathology 2001 39 33 42
60. Akslen LA LiVolsi VA Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma Cancer 2000 88 1902 1908
61. LiVolsi VA Asa SL The demise of follicular carcinoma of the thyroid gland Thyroid 1994 4 233 237
62. Lloyd RV Erickson LA Casey MB et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma AmJSurgPathol 2004 28 1336 1340
63. Stephenson TJ Benign lesions and mimics of malignancy in the thyroid gland CPD Bull - CellPathol 2003 4 139 144
64. Rosai J Carcangiu ML DeLellis RA Tumors of the thyroid gland Atlas of tumor pathology Third series, Fasicle 5 Washington Armed Forces Institute of Pathology 1992
65. Albores-Saavedra J Housini I Vuitch F et al. Macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases HumPathol 1991 22 1195 1205
66. Ruter A Nishiyama R Lennquist S Tall-cell variant of papillary thyroid cancer: Disregarded entity? World JSurg 1997 21 15 20
67. Evans HL Columnar-cell carcinoma of the thyroid: a report of two cases of an aggressive variant of thyroid carcinoma AmJClinPathol 1986 85 77 80
68. Nikiforov YE Erickson LA Nikiforova MN et al. Solid variant of papillary thyroid carcinoma: incidence, clinicopathologic characteristics, molecular analysis and biologic behaviour AmJSurgPathol 2001 25 1478 1484
69. Moreno Egea A Rodriguez Gonzales JM Sola Perez J et al. Clinicopathological study of the diffuse sclerosing variety of papillary carcinoma of the thyroid. Presentation of four new cases and review of the literature EurJSurgOncol 1994 20 7 11
70. LiVolsi VA Hyalinizing trabecular tumor of the thyroid: adenoma, carcinoma, or neoplasm of uncertain malignant potential? AmJSurgPathol 2000 24 1683 1684
71. de Matos PS Ferreira AP de Oliveira Facuri F Assumpcao LVM Metze K Ward LS Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy Histopathology 2005 47 391 401
72. Prasad ML Pellagata NS Huang Y Nagaraja HN de al Chapelle A Kloos RT Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors ModPathol 2005 18 48 45
73. Baloch ZW LiVolsi VA Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow ExpRevMolDiagn 2005 5 573 584
74. Chan JKC Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma AmJClinPathol 2002 117 16 18
75. Stephenson TJ Griffiths DWR Mills PM Comparison of Ulex europaeus I lectin binding and factor VIII-related antigen as markers of vascular endothelium in follicular carcinoma of the thyroid Histopathology 1986 10 251 260
76. Khan NF Perzin KH Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis In Sommers SC Rosen PP eds Pathology annual Norwalk, Connecticut Appleton-Century-Crofts 1983 18 221 253
77. LiVolsi VA Merino MJ Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT) In Sommers SC Rosen PP eds Pathology annual Norwalk, Connecticut Appleton-Century-Crofts 1994 29 99 120
78. Baloch ZW LiVolsi VA Post fine-needle aspiration histologic alterations of thyroid revisited AmJClinPathol 1999 112 311 316
79. Thompson LDR Wienke JA Paal E Frommel RA Adair CF Heffess CS A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with review of the English literature Cancer 2001 91 505 524
80. LiVolsi VA Baloch ZW Follicular neoplasms of the thyroid: view, biases and experiences AmJSurgPathol 2002 26 1064 1065
81. Lang W Choritz H Hundeshagen H Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings AmJSurgPathol 1986 10 246 255
82. Franssila KO Ackerman LV Brown CL Hendinger CE Follicular carcinoma SeminDiagnPathol 1985 2 101 122
83. LiVolsi VA Follicular lesions of the thyroid In Surgical pathology of the thyroid Philadelphia W.B. Saunders Co. 1990
84. Brennan MD Bergstrahl EJ van Heerden JA McConahey WM Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome Mayo ClinProc 1991 66 105 111
85. Coli A Bigotti G Zucchetti F Negro F Massi G Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia Histopathology 2002 40 12 21
86. Sobrinho-Simões M Nesland JM Holm R et al. Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study UltrastructPathol 1985 8 131 142
87. Asa SL My approach to oncocytic tumours of the thyroid JClinPathol 2004 57 225 232
88. Carcangiu ML Bianchiu S Savino D et al. Follicular Hürthle cell tumors of the thyroid gland Cancer 1991 68 1944 1953
89. Bronner MP LiVolsi VA Oxyphilic (Askenazy/Hürthle) cell tumors of the thyroid. Microscopic features predict malignant behaviour SurgPathol 1988 1 137 150
90. Cheung CC Ezzat S Raymar L et al. Molecular basis of Hürthle cell papillary thyroid carcinoma JClinEndocrinolMetab 2000 85 878 882
91. Cheung CC Ezzat S Freeman JL et al. Immunohistochemical diagnosis of papillary thyroid carcinoma ModPathol 2001 14 338 342
92. Mai KT Bokkary R Yazdi HM Thomas J Commons AS Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine like changes Histopathology 2002 40 133 142
93. Williams ED Medullary carcinoma of the thyroid In De Groot LJ Cahill GR Odell WD et al. eds Endocrinology
94. Sikri KL Varndell IM Hamid QA et al. Medullary carcinoma of the thyroid gland: an immunocytochemical and histochemical study of 25 cases using eight separate markers Cancer 1985 56 2481 2491
95. Schmid KW Fischer-Colbrie R Hagn C Jasani B Williams ED Winkler H Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid AmJSurgPathol 1987 11 551 556
96. Scopsi L Sampietro G Boracchi P et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients Cancer 1996 78 2173 2183
97. Perry A Molberg K Albores-Saavedra J Physiologic versus neoplastic c-cell hyperplasia of the thyroid Cancer 1996 77 750 756
98. Bugalho MJ Domingues R Sobrinho L Molecular diagnosis of multiple endocrine neoplasia Type 2 Expert RevMolDiagn 2003 3 769 779
99. Shroder S Bocker W Baisch H et al. Prognostic factors in medullary thyroid carcinoma: survival in relation to age, sex, stage, histology, immunohistochemistry and DNA content Cancer 1988 61 806 816
100. Carcangiu ML Zampi G Rosai J Poorly differentiated (insular) thyroid carcinoma: a reinterpretation of Langhan's wuchernde struma AmJSurgPathol 1984 8 655 668
101. Rodriguez JM Parrilla P Moreno A et al. Insular carcinoma: an infrequent subtype of thyroid cancer JAmCollSurg 1998 187 503 508
102. Burt AD Kerr DJ Brown IL Boyle P Lymphoid and epithelial markers in small cell anaplastic thyroid tumours JClinPathol 1985 38 893 896
103. Lam KY Lui MC Lo CY Cytokeratin expression profiles in thyroid carcinomas EurJSurgOncol 2001 27 631 635
104. Wan S-K Chan JKC Tang S-K Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Riedel's thyroiditis AmJClinPathol 1996 105 388 393
105. Kapp DS LiVolsi VA Sanders MM Anaplastic carcinoma following well-differentiated thyroid cancer: etiologic considerations Yale JBiolMed 1982 55 521 528
106. Weiss LM Comparative histologic study of 43 metastasising and non-metastasising adrenocortical tumours AmJSurgPathol 1984 8 163 169
107. Wick MR Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma AmJPathol 1986 122 343 352
108. Gaffey MJ Traweek ST Mills SE et al. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular and renal cell carcinoma HumPathol 1992 23 144 153
109. Haak HR Fleuren GJ Neuroendocrine differentiation of adrenocortical tumors Cancer 1995 75 860 864
110. Munro LM Kennedy A McNicol A-M The expression of inhibin/activin subunits in the human adrenal cortex and its tumors JEndocrinol 1999 161 341 347
111. Busam KJ Iversen K Coplan KA et al. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors AmJSurgPathol 1998 22 57 63
112. Zhang PJ Genega EM Timaszewski JE Pasha TL LiVolsi VA The role of calretinin, inhibin, melan-a, bcl-2, and c-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study ModPathol 2003 16 591 597
113. Weiss LM Medeiros LJ Vickery AL Pathologic features of prognostic significance in adrenocortical carcinoma AmJSurgPathol 1989 13 202 206
114. van Slooten H Schaberg A Smeenk D Moolenaar AJ Morphologic characteristics of benign and malignant adrenocortical tumors Cancer 1985 55 766 773
115. Hough AJ Hollifield JW Page DL Hartmann WH Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data AmJClinPathol 1979 72 390 399
116. Cibas ES Madeiros LJ Weinberg YS Gelb AB Weiss LM Cellular DNA profiles of benign and malignant adrenocortical tumours AmJSurgPathol 1990 10 948 955
117. Haak HR Cornelisse CJ Hermans J Cobben L Fleuren GJ Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma BrJCancer 1993 68 151 155
118. Scmitt A Saremaslani S Schmid S et al. IGFII and MIB-1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumors Histopathology in press
119. Sullivan M Boileau M Hodges CV Adrenal cortical carcinoma JUrol 1978 120 660 665
120. MacFarlane DA Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases AnnRCollSurgEngl 1958 23 155 186
121. Linnoila RI Keiser HR Steinberg SM Lack EE Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinico-pathologic study of 120 cases including unusual histologic features HumPathol 1990 11 1168 1180
122. Unger P Hoffman K Pertsemlidis D Thung S Wolfe D Maneko M S100 protein-positive sustentacular cells in malignant and locally aggressive phaeochromocytomas ArchPatholLabMed 1991 115 484 487
123. Salmenkivi K Heikkilä P Haglund C Louhimo J Arola J Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytmas Histopathology 2003 43 62 71